Expression of protease-activated receptor-1 and -2 in orofacial granulomatosis

Oral Diseases

Volumn 13, Issue 4, 2007, Pages 419-425

  Ketabchi, S ^a   Massi, D ^a   Ficarra, G ^a   Rubino, I ^a   Franchi, A ^a   Paglierani, M ^a   Simoni, A ^a   Capodiferro, S ^b   Favia, G ^b   Maiorano, E ^b   Tarantini, F ^a   Cirino, G ^c   Santucci, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

COX 1; COX 2; Immunohistochemistry; MMP 2; MMP 9; Orofacial granulomatosis; PAR 1; PAR 2

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; EDEMA; EPITHELIOID CELL; FEMALE; GENE OVEREXPRESSION; GIANT CELL; GRANULOMATOUS INFLAMMATION; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LICHENOID; MALE; MELKERSSON ROSENTHAL SYNDROME; MONONUCLEAR CELL; MOUTH CAVITY; MOUTH MUCOSA; OROFACIAL GRANULOMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; CHILD; CROHN DISEASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EDEMA; EPITHELIOID CELLS; FEMALE; GIANT CELLS; GRANULOMATOSIS, OROFACIAL; HISTIOCYTES; HUMANS; LEUKOCYTES, MONONUCLEAR; LICHENOID ERUPTIONS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELKERSSON-ROSENTHAL SYNDROME; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RETROSPECTIVE STUDIES;

EID: 34250664500     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01317.x     Document Type: Article

References (20)

1. Bogenrieder T, Rogler G, Vogt T, Landthaler M, Stolz W (2003). Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology 206 : 273 278.
2. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumourigenesis of breast cancer cells. Cell 120 : 303 313.
3. Curran S, Murray GI (1999). Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189 : 300 308.
4. Daoud MS, Rogers RS. III. (1995). Melkersson-Rosenthal syndrome. Semin Dermatol 14 : 135 139.
5. Ficarra G, Cicchi P, Amorosi A, Piluso S (1993). Oral Crohn's disease and pyostomatitis vegetans. An unusual association. Oral Surg Oral Med Oral Pathol 75 : 220 224.
6. Girlich C, Bogenrieder T, Palitzsch KD, Scholmerich J, Lock G (2002). Orofacial granulomatosis as initial manifestation of Crohn's disease: a report of two cases. Eur J Gastroenterol Hepatol 14 : 873 876.
7. He SH (2004). Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10 : 309 318.
8. Holzhausen M, Spolidorio LC, Vergnolle N (2005). Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats. J Dent Res 84 : 154 159.
9. Leão JC, Hodgson T, Scully C, Porter S (2004). Orofacial granulomatosis. Aliment Pharmacol Ther 20 : 1019 1027.
10. MacFarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R (2001). Proteinase-activated receptors. Pharmacol Rev 53 : 245 282.
11. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L (2003). The multiform and variable patterns of onset of orofacial granulomatosis. J Oral Pathol Med 32 : 200 205.
12. Ossovskaya VS, Bunnett NW (2004). Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84 : 579 621.
13. Pei D (2005). Matrix metalloproteinases target protease-activated receptors on the tumour cell surface. Cancer Cell 7 : 207 208.
14. Rogers RS (1996). Melkersson-Rosenthal syndrome and orofacial granulomatosis. Dermatol Clin 14 : 371 379.
15. van de Scheur MR, van der Waal RI, Volker-Dieben HJ, Klinkenberg-Knol EC, Starink TM, van der Waal I (2003). Orofacial granulomatosis in a patient with Crohn's disease. J Am Acad Dermatol 49 : 952 954.
16. Sciubba JJ, Said-Al-Naief N (2003). Orofacial granulomatosis: presentation, pathology and management of 13 cases. J Oral Pathol Med 32 : 576 585.
17. Vergnolle N, Cellars L, Mencarelli A et al. (2004). A role for proteinase-activated receptor-1 in inflammatory bowel diseases. J Clin Invest 114 : 1444 1456.
18. van der Waal RI, Schulten EA, van der Meij EH, van de Scheur MR, Starink TM, van der Waal I (2002). Cheilitis granulomatosa: overview of 13 patients with long-term follow-up-results of management. Int J Dermatol 41 : 225 229.
19. Weisenfeld D, Ferguson MM, Mitchell DN et al. (1985). Orofacial granulomatosis: a clinical and pathological analysis. Q J Med 54 : 101 113.
20. Wilson SR, Gallagher S, Warpeha K, Hawthorne SJ (2004). Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors. Prostate 60 : 168 174.